![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Maelor | LSE:MLR | London | Ordinary Share | GB00B2QBY649 | ORD 70P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 100.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:0606C Maelor PLC 14 August 2007 Maelor plc 14 August 2007 Maelor plc ('Maelor') Rule 26 Compliance Information pertaining to Rule 26 of the AIM Rules for Maelor may be found on the following website: www.maelor.plc.uk Enquiries: Financial Dynamics Limited +44(0) 20 7831 3113 Billy Clegg / Edward Westropp Noble & Company Limited +44(0) 20 7763 2200 Matthew Hall/Sam Reynolds Maelor plc +44(0) 1244 625150 Tim Wright Notes to Editors Maelor is a specialist hospital medicines company with expertise in both pharmaceuticals and medical devices. The Maelor Group comprises Maelor plc, Maelor Pharmaceuticals Limited and Acorus Therapeutics Limited. This information is provided by RNS The company news service from the London Stock Exchange END MSCGUUQCRUPMGGC
1 Year Maelor Chart |
1 Month Maelor Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions